Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.71 USD
Change Today +0.08 / 4.91%
Volume 143.7K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter S. Lawrence J.D.

President, Chief Operating Officer, General Counsel and Secretary, ArQule Inc.
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Peter S. Lawrence, J.D. has been the President at ArQule, Inc. since April 11, 2008. Mr. Lawrence has also been the Chief Operating Officer of ArQule, Inc. since October 4, 2007 and has been its General Counsel and Secretary since April 2006. He served as the Principal Financial Officer of ArQule, Inc. since August 31, 2007. He joined ArQule, Inc. since in April 2006 as an Executive Vice President, Chief Business Officer. Mr. Lawrence was a Special Partner at Pod ...

Read Full Background

Corporate Headquarters*

One Wall Street
Burlington, Massachusetts 01803

United States

Phone: 781-994-0300
Fax: 781-376-6019

Board Members Memberships*



Amherst College
Boston University School of Law

Other Affiliations*

Annual Compensation*

Total Annual Compensation$413,921

Stock Options*

All Other Compensation$8,400
Exercisable Options1,001,000
Unexercisable Options345,750
Total Number of Options1,346,750

Total Compensation*

Total Annual Cash Compensation$580,646
Total Short Term Compensation$413,921
Other Long Term Compensation$8,400
Total Calculated Compensation$825,776
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARQL:US $1.71 USD +0.08


Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
Michael P. Bailey Chief Executive Officer, President, Secretary and Director
AVEO Pharmaceuticals, Inc.
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at